相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review
Cristiana Freixo et al.
JOURNAL OF VASCULAR SURGERY (2020)
Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon
Leticia G. Mariani et al.
PEDIATRIC BLOOD & CANCER (2019)
Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up
Zuopeng Wang et al.
JOURNAL OF DERMATOLOGY (2019)
Vascular tumors in infants and adolescents
Moritz Wildgruber et al.
INSIGHTS INTO IMAGING (2019)
Vascular anomaly cases for the pediatric hematologist oncologistsAn interdisciplinary review
Denise M. Adams et al.
PEDIATRIC BLOOD & CANCER (2018)
Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon
Y. Ji et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Successful management of steroid-resistant vascular tumors associated with the Kasabach-Merritt phenomenon using sirolimus
Xiaoyun Tan et al.
JOURNAL OF DERMATOLOGY (2018)
Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin
Suzanne P. MacFarland et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)
Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma
Huaijie Wang et al.
PEDIATRIC DERMATOLOGY (2018)
Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options
Irene Schmid et al.
WORLD JOURNAL OF PEDIATRICS (2018)
Impact of sirolimus treatment for refractory kaposiform hemangioendothelioma with exacerbation of the disease 10 years after initial diagnosis
Naoki Sakata et al.
RARE TUMORS (2018)
The effects of sirolimus on Kasabach-Merritt phenomenon coagulopathy
O. Boccara et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study
Yi Ji et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review
Marion Nadal et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Treatment of kaposiform hemangioendothelioma and tufted angioma
Xiao Han Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Treatment of Corticosteroid-Resistant Vascular Tumors Associated with the Kasabach-Merritt Phenomenon in Infants: An Approach with Transcatheter Arterial Embolization Plus Vincristine Therapy
Xiaoyun Tan et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon
Ciara O'Rafferty et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Laryngomalacia and Complicated, Life-threatening mTOR-positive Kaposiform Hemangioendothelioma Cured by Supraglottoplasty and Sirolimus
U. Schroeder et al.
KLINISCHE PADIATRIE (2014)
Kaposiform Hemangioendothelioma: Atypical Features and Risks of Kasabach-Merritt Phenomenon in 107 Referrals
Stacy E. Croteau et al.
JOURNAL OF PEDIATRICS (2013)
Consensus-Derived Practice Standards Plan for Complicated Kaposiform Hemangioendothelioma
Beth A. Drolet et al.
JOURNAL OF PEDIATRICS (2013)
Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with kasabach-merritt phenomenon
Israel Fernandez-Pineda et al.
PEDIATRIC BLOOD & CANCER (2013)
Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia
Cassandra D. Josephson et al.
BLOOD (2012)
Tufted angioma-associated Kasabach-Merritt syndrome treated with embolization and vincristine
P. D. Yesudian et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2008)
Early surgical intervention in a patient with Kasabach-Merritt phenomenon
BA Drolet et al.
JOURNAL OF PEDIATRICS (2001)
分享论文
